Overview

Abbott Laboratories is an American healthcare company established in 1888 by Wallace Calvin Abbott. Headquartered in North Chicago, Illinois, it operates worldwide with more than 90,000 employees across over 130 countries. Abbott develops, manufactures and markets a wide range of health products that address diagnosis, treatment and long‑term care needs.

Main activities and product areas

Abbott's portfolio covers several major categories. Its work spans pharmaceuticals, branded and generic medicines, diagnostic systems and tests, nutritional products for infants and adults, and vascular and other medical devices. The company is particularly notable for glucose monitoring technologies for people with diabetes and for a broad mix of diagnostics used in hospitals and laboratories.

  • Diagnostics: laboratory instruments, point‑of‑care tests and assays for infectious diseases, cardiology and other conditions — often used in clinical and research settings. Diagnostics enable earlier detection and treatment decisions.
  • Medical devices: vascular stents, catheters and other interventional products used by clinicians in cardiovascular care.
  • Nutrition: clinical and consumer nutrition products, from infant formula to specialized medical nutrition.
  • Pharmaceuticals: medicines for chronic and acute conditions, including therapies for autoimmune diseases such as rheumatoid arthritis.

Historical development and corporate changes

Founded in the late 19th century, Abbott began as a small laboratory business and grew into a diversified healthcare firm over decades. In 2013 the company completed a corporate separation that created AbbVie, its research‑based pharmaceutical spin‑off, allowing Abbott to focus on diversified medical products and diagnostics. Abbott has expanded by acquiring complementary businesses, including the 2017 acquisition of Alere, a company specializing in rapid diagnostics, for approximately $4.48 billion.

Innovation and notable products

Abbott has been active in developing point‑of‑care and consumer health technologies. A widely reported milestone was the U.S. Food and Drug Administration clearance in September 2017 for a consumer version of the FreeStyle Libre, a flash glucose monitoring system that reduced the need for routine finger‑prick checks for many people with diabetes. Its diagnostic platforms and nutrition science products are similarly influential in clinical practice and consumer health.

Global footprint and importance

With operations in more than 130 countries and global manufacturing and research facilities, Abbott supplies hospitals, clinics and consumers internationally. Its scale supports large distribution networks and investments in research, quality systems and regulatory compliance. Abbott's products are used in routine care, emergency medicine and long‑term disease management.

Distinctions and considerations

Abbott is distinct for its multi‑sector approach that combines pharmaceutical products, diagnostic technologies and medical devices under one corporate umbrella. Its regional head office remains in North Chicago, and it collaborates with healthcare providers and regulatory bodies worldwide. The company is an example of a diversified healthcare manufacturer that balances consumer‑facing nutrition and monitoring devices with professional diagnostic and vascular products.

For further information about specific product lines, regulatory approvals and recent corporate actions, refer to Abbott's official communications and publicly available reports. Additional resources and product details can be found through industry and regulatory information channels. Health care professionals and patients often consult these sources before making clinical or purchasing decisions.

Rheumatoid arthritis, diabetes, and other disease areas remain important targets for Abbott's research and commercial activities as it continues to develop diagnostics and therapies tailored to clinical needs.